Prescribed by oncologists for the treatment of: 🔹 Hepatocellular Carcinoma (HCC): Unresectable liver cancer. 🔹 Renal Cell Carcinoma (RCC): Advanced kidney cancer, especially when other therapies have failed. 🔹 Differentiated Thyroid Carcinoma: Progressive thyroid cancer that no longer responds to radioactive iodine treatment.

Dosage and administration

Sales Unit: 1 Bottle (120 Tablets). ⚠️ STRICTLY BY PRESCRIPTION: Standard Dosage: Typically 400 mg (2 tablets) twice daily (Total daily dose: 800 mg). Administration: Swallow tablets whole with a glass of water. Food Interaction: Take on an empty stomach (1 hour before eating) or with a low-fat meal. High-fat meals reduce bioavailability! Duration: Treatment continues as long as clinical benefit is observed or until toxicity occurs.

⛔ Pregnancy & Breastfeeding: Can cause fetal harm. Strict contraception is required. Severe hypersensitivity to Sorafenib. Children and adolescents (safety not established). Use with caution in patients with cardiac conditions (QT prolongation), hypertension, or bleeding disorders.

Common side effects (require medical monitoring): ✋🦶 Hand-Foot Skin Reaction: Redness, pain, or peeling of palms and soles. 📉 Diarrhea, fatigue, weight loss. 🩸 Hypertension (high blood pressure). 🤕 Hair thinning or loss (alopecia).

Sorafekast — Sorafenib 200 mg, 120 product-page.units_short, Aprazer

100% original product

Active ingredient

Sorafenib

Manufacturer

Aprazer

Dosage 200 mg

Dosage form Tablets

Tablets per pack 120

Sorafekast — Sorafenib 200 mg Tablets

Name: Sorafekast
Brand: Aprazer
SKU: PROD-178
Price: 4309 UAH
Availability: InStock

4309₴ ~~4925₴~~ -13%

Sorafekast 200 mg (Sorafenib) is a targeted therapy drug and a generic equivalent to Nexavar. It belongs to the class of multikinase inhibitors, working by slowing down the growth of cancer cells and cutting off the blood supply that keeps tumors growing.

Manufacturer: Aprazer Healthcare (India). ⚠️ Note: Contains 120 tablets per bottle. This quantity is typically sufficient for a 1-month treatment course at standard dosage.

Key Features:

✅ Targeted Action: Specifically targets tumor cell receptors to inhibit disease progression.
✅ Proven Efficacy: Used globally for advanced stages of liver and kidney cancer.
✅ Affordability: High-quality formulation from Aprazer at a fraction of the cost of the brand-name drug.

Prescribed by oncologists for the treatment of:

🔹 Hepatocellular Carcinoma (HCC): Unresectable liver cancer.
🔹 Renal Cell Carcinoma (RCC): Advanced kidney cancer, especially when other therapies have failed.
🔹 Differentiated Thyroid Carcinoma: Progressive thyroid cancer that no longer responds to radioactive iodine treatment.

Sales Unit: 1 Bottle (120 Tablets).

⚠️ STRICTLY BY PRESCRIPTION:

Standard Dosage: Typically 400 mg (2 tablets) twice daily (Total daily dose: 800 mg).
Administration: Swallow tablets whole with a glass of water.
Food Interaction: Take on an empty stomach (1 hour before eating) or with a low-fat meal. High-fat meals reduce bioavailability!
Duration: Treatment continues as long as clinical benefit is observed or until toxicity occurs.

⛔ Pregnancy & Breastfeeding: Can cause fetal harm. Strict contraception is required.
Severe hypersensitivity to Sorafenib.
Children and adolescents (safety not established).
Use with caution in patients with cardiac conditions (QT prolongation), hypertension, or bleeding disorders.

Common side effects (require medical monitoring):